Litcius/Paper detail

Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials

Feiyu Wang, Yinjun Mao, Hang Wang, Yiwei Liu, Pinfang Huang

2021Clinical Drug Investigation62 citationsDOI

Topics & Concepts

SemaglutideMedicineRelative riskPlaceboDulaglutideDiabetic retinopathyInternal medicineRandomized controlled trialMeta-analysisType 2 diabetesDiabetes mellitusType 2 Diabetes MellitusLower riskConfidence intervalExenatideEndocrinologyLiraglutideAlternative medicinePathologyDiabetes Treatment and ManagementRetinal Diseases and TreatmentsHyperglycemia and glycemic control in critically ill and hospitalized patients
Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials | Litcius